Cerebral Autoregulation Assessment Using the Near Infrared Spectroscopy 'NIRS-Only' High Frequency Methodology in...

Area of Science:

• Neuroscience
• Critical Care Medicine
• Biomedical Engineering

Background:

• Impaired cerebral autoregulation (CA) is linked to adverse clinical outcomes in critically ill patients.
• Near-infrared spectroscopy (NIRS) is a non-invasive optical technique used to monitor cerebral hemodynamics.
• Estimating CA non-invasively is crucial for managing neurological conditions in intensive care units (ICUs).

Purpose of the Study:

• To assess the clinical feasibility of a NIRS-only cerebral autoregulation (CA) methodology in an ICU setting.
• To determine the relationship between NIRS-derived CA estimates and clinical outcomes in critically ill patients.
• To validate a previously developed 'NIRS-only' CA assessment technique for broader ICU application.

Main Methods:

• Bilateral NIRS measurements were conducted for 1-2 hours in 54 critically ill patients.
• Transfer function analysis (TFA) was used to estimate CA from high-frequency oxyhemoglobin (oxyHb) and deoxyhemoglobin (deoxyHb) signals.
• Automated selection criteria identified 67% of 10-minute data segments exhibiting 'high-pass filter' characteristics for robust CA estimation.

Main Results:

• The NIRS-only CA methodology was found to be feasible in the studied ICU population.
• In 34 neurology patients, a higher median low-frequency (LF) phase shift was observed in survivors (13°) compared to non-survivors (0.83°, p=0.0167).
• Automated segment selection improved the robustness and consistency of CA estimations.

Conclusions:

• The NIRS-only CA estimation method appears clinically feasible for ICU populations, particularly with automated segment selection.
• This non-invasive approach offers an alternative to methods requiring invasive arterial blood pressure monitoring.
• Further validation is needed, but the NIRS-only methodology shows promise for non-invasive CA assessment and outcome prediction in critical care.